SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-284030
Filing Date
2015-08-10
Accepted
2015-08-10 09:00:19
Documents
11
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d938387d10q.htm 10-Q 354615
2 CERTIFICATION d938387dex311.htm EX-31.1 6030
3 CERTIFICATION d938387dex312.htm EX-31.2 6074
4 CERTIFICATION d938387dex321.htm EX-32.1 2745
5 CERTIFICATION d938387dex322.htm EX-32.2 2800
  Complete submission text file 0001193125-15-284030.txt   2746255

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT bdsi-20150630.xml EX-101.INS 370045
7 XBRL TAXONOMY EXTENSION SCHEMA bdsi-20150630.xsd EX-101.SCH 44294
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bdsi-20150630_cal.xml EX-101.CAL 51084
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bdsi-20150630_def.xml EX-101.DEF 131963
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE bdsi-20150630_lab.xml EX-101.LAB 337803
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bdsi-20150630_pre.xml EX-101.PRE 227934
Mailing Address 4131 PARKLAKE AVENUE SUITE 225 RALEIGH NC 27612
Business Address 4131 PARKLAKE AVENUE SUITE 225 RALEIGH NC 27612 919 582 9050
BIODELIVERY SCIENCES INTERNATIONAL INC (Filer) CIK: 0001103021 (see all company filings)

IRS No.: 352089858 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31361 | Film No.: 151039345
SIC: 2834 Pharmaceutical Preparations